Antiparkinson Agents (pharmacology) < Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 225.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000200 (2001)	O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
000218 (2001)	E. Apartis [France] ; F. Tison ; P. Arné ; C P Jedynak ; M. Vidailhet	Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor.
000222 (2001)	S. Thobois [France] ; S. Guillouet ; E. Broussolle	Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
000224 (2002)	Luc J P. Defebvre [France] ; Pierre Krystkowiak ; Jean-Louis Blatt ; Alain Duhamel ; Jean-Louis Bourriez ; Myriame Périna ; Serge Blond ; Jean-Daniel Guieu ; Alain Destée [France]	Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease.
000226 (2002)	M L Welter [France] ; J L Houeto ; S. Tezenas Du Montcel ; V. Mesnage ; A M Bonnet ; B. Pillon ; I. Arnulf ; B. Pidoux ; D. Dormont ; P. Cornu ; Yves Agid [France]	Clinical predictive factors of subthalamic stimulation in Parkinson's disease.
000227 (2001)	O. Rascol [France] ; J. Ferreira ; J L Montastruc	[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs].
000234 (2002)	I. Arnulf [France] ; E. Konofal ; M. Merino-Andreu ; J L Houeto ; V. Mesnage ; M L Welter ; L. Lacomblez ; J L Golmard ; J P Derenne ; Yves Agid [France]	Parkinson's disease and sleepiness: an integral part of PD.
000239 (2002)	Paul Krack [France] ; Valérie Fraix ; Alexandre Mendes ; Alim-Louis Benabid ; Pierre Pollak	Postoperative management of subthalamic nucleus stimulation for Parkinson's disease.
000242 (2002)	M. Bailbé ; S. Karolewicz ; J Ph Neau ; P. Dumas ; R. Gil	[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
000244 (2002)		Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000245 (2001)	J. Xie [France] ; P. Krack ; A L Benabid ; P. Pollak	Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
000246 (2002)	S. Thobois [France] ; P. Mertens ; M. Guenot ; M. Hermier ; H. Mollion ; M. Bouvard ; G. Chazot ; E. Broussolle ; M. Sindou	Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.
000248 (2002)	I. Ghorayeb ; F. Yekhlef ; V. Chrysostome ; E. Balestre ; B. Bioulac ; F. Tison	Sleep disorders and their determinants in multiple system atrophy
000255 (2002)	D. Devos [France] ; Ph Derambure ; J L Bourriez ; D F Cassim ; S. Blond ; J D Guieu ; A. Destée ; L. Defebvre	Influence of internal globus pallidus stimulation on motor cortex activation pattern in Parkinson's disease.
000259 (2002)	André Nieoullon [France]	Dopamine and the regulation of cognition and attention.
000261 (????)	Bernard Bruguerolle [France] ; Nicolas Simon	Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function.
000268 (2002)	Anne-Marie Bonnet [France]	[Alpha-2 adrenergic receptors and Parkinson's disease].
000270 (2002)		Selegiline: a second look. Six years later: too risky in Parkinson's disease.
000286 (2002)	V. Czernecki [France] ; B. Pillon ; J L Houeto ; J B Pochon ; R. Levy ; B. Dubois	Motivation, reward, and Parkinson's disease: influence of dopatherapy.
000289 (2003)	Olivier Rascol [France] ; C. Brefel-Courbon ; P. Payoux ; J. Ferreira	The management of patients with early Parkinson's disease.
000297 (2002)	Y. Tsuboi [États-Unis] ; M. Baker ; M L Hutton ; R J Uitti ; O. Rascol ; M-B Delisle ; X. Soulages ; J R Murrell ; B. Ghetti ; M. Yasuda ; O. Komure ; S. Kuno ; K. Arima ; N. Sunohara ; T. Kobayashi ; Y. Mizuno ; Z K Wszolek	Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024